Valor20202021202220232024TTMFlujo de caja de las actividades de inversión-7.26 M11.78 M9.7 M10.58 M8.03 M5.3 MFlujo de caja de las actividades financieras61.4 M7.5 M8.02 M8.84 M9.53 M—Flujo de caja libre-31.28 M-36.78 M-23.12 M-18.34 M-19.83 M-22.01 M
Pluri Inc
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.